CS-Pharmaeutial hanbk 瑞士信贷-年日本医药行业手册.pdf

CS-Pharmaeutial hanbk 瑞士信贷-年日本医药行业手册.pdf

  1. 1、本文档共58页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
10 April 2008 Asia Pacific/Japan Equity Research Major Pharmaceuticals (Pharmaceuticals) / MARKET WEIGHT Pharmaceutical handbook 2008 Research Analysts SECTOR REVIEW Fumiyoshi Sakai 81 3 4550 9737 fumiyoshi.sakai@ Overview of Japan's medical system, market structure and investment indicators ■ Introduction: In this, our first pharmaceutical handbook, we hope to provide investors with an understanding of Japanís medical system and drug market through encompassing basic explanations and materials. In Chapter I, we take a look at macro indicators related to Japanese healthcare and health insurance systems. We turn to the US health system in Chapter II, which is of much interest in 2008óa presidential election year. It also refers to the system in EU. In Chapter III, we look at Japanís universal health insurance

文档评论(0)

xinxinasd + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档